JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Akt

A4451 Deguelin

Summary: Anticancer and antiviral agent

Soluble in DMSO
A5072 GSK690693

Target: Akt|PKC|PKG|PKA|Prk

Summary: Pan-AKT inhibitor,ATP-competitive and potent

≥21.25 mg/mL
A5653 AT7867

Target: Akt|PKA|p70 rsk

Summary: Akt1/2/3 and p70S6K/PKA inhibitor

≥16.9 mg/mL
A5884 PHT-427

Summary: Akt and PDPK1 inhibitor

insoluble in H2O; ≥20.5 mg/mL
A1387 AZD5363
3 Citation

Target: Akt

Summary: AKT inhibitor,pyrrolopyrimidine derived

≥21.45 mg/mL
A8309 Perifosine
1 Citation

Target: Akt

Summary: Akt inhibitor
A8541 Triciribine
5 Citation

Summary: Akt inhibitor,highly selective

insoluble in H2O; insoluble in EtOH; ≥118.4 mg/mL
A8616 A-674563

Target: Cyclin-Dependent Kinases|Akt|GSK-3|ERK|PKC|PKA|RSK

Summary: Akt1/PKA/CDK2 inhibitor,potent and selective

insoluble in EtOH; ≥23.8 mg/mL
A8617 CCT128930 HCl

Target: Akt

Summary: AKT inhibitor

insoluble in H2O; ≥17.1 mg/mL
A8618 Palomid 529

Summary: PI3K/Akt/mTOR inhibitor

insoluble in EtOH; insoluble in H2O; ≥41 mg/mL